Small-cell lung cancer: treatment progress and prospects.

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

1991 • 1,401 citations

A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer

1992 • 1,295 citations

Rationale for the use of alternating non-cross-resistant chemotherapy.

1982 • 545 citations

Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group.

1992 • 532 citations

MEDICAL RESEARCH COUNCIL COMPARATIVE TRIAL OF SURGERY AND RADIOTHERAPY FOR PRIMARY TREATMENT OF SMALL-CELLED OR OAT-CELLED CARCINOMA OF BRONCHUS

1973 • 528 citations

Prophylactic Cranial Irradiation for Patients With Small-Cell Lung Cancer in Complete Remission

1995 • 513 citations

Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung Cancer

1991 • 444 citations

CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer.

1992 • 443 citations

Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.

1990 • 385 citations

Alkylating agents in bronchogenic carcinoma

1969 • 353 citations

VP-16 and cisplatin as first-line therapy for small-cell lung cancer.

1985 • 301 citations

Frequency of residual and metastatic tumor in patients undergoing curative surgical resection for lung cancer.

1973 • 298 citations

United States lung carcinoma incidence trends: Declining for most histologic types among males, increasing among females

1996 • 264 citations

Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer

1994 • 260 citations

Staging and prognostic factors in small cell lung cancer: a consensus report

1989 • 256 citations

Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer.

1994 • 252 citations

Histopathologic classification of small cell lung cancer changing concepts and terminology

1988 • 220 citations

Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial.

1996 • 206 citations

Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study.

1987 • 204 citations

Review of occupational lung carcinogens

1996 • 189 citations

Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer.

1985 • 188 citations

The Epidemiology of Lung Cancer

1993 • 174 citations

Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line.

1991 • 165 citations

Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study.

1995 • 157 citations

Presenting conditions of 1539 population-based lung cancer patients by cell type and stage in new hampshire and vermont

1985 • 157 citations

Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC)

1994 • 144 citations

Treatment of patients with small-cell lung cancer refractory to etoposide and cisplatin with the topoisomerase I poison topotecan.

1996 • 132 citations

Activity of docetaxel (Taxotere) in small cell lung cancer

1994 • 130 citations

THE ROLE OF BRONCHOSCOPY IN LUNG CANCER

1993 • 130 citations

A randomized comparison of high-dose versus conventional-dose cyclophosphamide, doxorubicin, and vincristine for extensive-stage small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group.

1987 • 129 citations

Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer.

1995 • 126 citations

Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited small-cell lung cancer.

1988 • 125 citations

Lung cancer: Clinical trial of radiotherapy alone vs. Radiotherapy plus cyclophosphamide

1972 • 123 citations

The superiority of combination chemotherapy over single agent chemotherapy in small cell lung carcinoma

1979 • 111 citations

Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors.

1997 • 108 citations

Paraneoplastic Syndromes Associated With Lung Cancer

1993 • 99 citations

The molecular and cellular basis of human lung cancer.

1994 • 93 citations

Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities.

1997 • 89 citations

Isolated Pleural Effusion in Small Cell Lung Carcinoma: Favorable Prognosis

1982 • 80 citations

Female Lung Cancer

1996 • 78 citations

Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer.

1986 • 72 citations

THE ROLE OF TRANSTHORACIC NEEDLE BIOPSY FOR THE DIAGNOSIS AND STAGING OF LUNG CANCER

1993 • 69 citations

Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group.

1993 • 66 citations

Diagnosis and typing of lung carcinomas by cytopathologic methods. A review of 108 cases

1986 • 66 citations

Overview of chemotherapy for small cell lung cancer.

1997 • 61 citations

Dose-ranging study of recombinant human granulocyte-macrophage colony-stimulating factor in small-cell lung carcinoma.

1994 • 57 citations

Intensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancer

1989 • 56 citations

Paraneoplastic syndromes associated with small cell lung cancer.

1997 • 53 citations

Scintigraphic imaging of small-cell lung cancer with [111In]pentetreotide, a radiolabelled somatostatin analogue

1994 • 40 citations

Application of an Algorithm for Staging Small-cell Lung Cancer Can Save One Third of the Initial Evaluation Costs

1993 • 33 citations

Gemcitabine and etoposide in small cell lung cancer: phase I and II trials.

1997 • 32 citations

Somatostatin receptor imaging in small cell lung cancer

1996 • 28 citations

Basic science of small cell lung cancer.

1997 • 26 citations

Clinical Manifestations of Lung Cancer

1993 • 24 citations

Surgical treatment of peripheral small cell lung cancer.

1997 • 21 citations

Detection and Staging of Small Cell Lung Carcinoma with a Technetium-labeled Monoclonal Antibody A Comparison with Standard Staging Methods

1992 • 19 citations

18F-fluorodeoxyglucose PET scans in lung cancer.

1996 • 19 citations

Diagnostic Tests for Lung Cancer

1993 • 18 citations

Paclitaxel, carboplatin, and oral etoposide in the treatment of small cell lung cancer.

1996 • 10 citations

Extensive small-cell lung cancer. A randomized comparison of two chemotheraphy programs with early crossover in instances of failure

1992 • 8 citations

Single-agent paclitaxel in the treatment of small cell lung cancer.

1996 • 6 citations

Phase I study of cisplatin, etoposide, and paclitaxel in patients with extensive-stage small cell lung cancer: a University of Colorado Cancer Center study.

1996 • 6 citations